ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,283Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 50

$801K Total Retail Price of All Prescriptions

Rank: 1 out of 50

200 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alaska
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 200 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 200 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 5,297 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$86 was the average price of a prescription from this provider, compared to $76 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alaska
LEVOTHYROXINE SODIUM 341 158 1 2
LISINOPRIL 334 207 2 1
SIMVASTATIN 269 181 3 3
NEXIUM 239 127 4 12
FUROSEMIDE 224 163 5 5
ATORVASTATIN CALCIUM 184 119 6 10
METFORMIN HCL 177 102 7 9
PRAMIPEXOLE DIHYDROCHLORIDE 165 128 8 55
ACTOS 146 96 9 73
ZOLPIDEM TARTRATE 141 51 10 11
OMEPRAZOLE 138 60 11 4
BYSTOLIC 135 58 12 31
DIOVAN 132 96 13 23
AMLODIPINE BESYLATE 128 94 14 6
METOPROLOL SUCCINATE 123 82 15 8
POTASSIUM CHLORIDE 117 61 16 13
CLOPIDOGREL 117 61 16 37
ZETIA 116 82 18 41
VYTORIN 114 81 19 49
TOPIRAMATE 106 0 20 71
TEKTURNA 95 83 21 92
CRESTOR 95 48 21 36
JANUVIA 93 32 23 74
KLOR-CON M20 92 65 24 57
HYDROCHLOROTHIAZIDE 89 39 25 14
SPIRONOLACTONE 87 13 26 35
PANTOPRAZOLE SODIUM 86 66 27 26
PLAVIX 86 44 27 60
DONEPEZIL HCL 85 33 29 30
GLIPIZIDE XL 84 67 30 95
METHOTREXATE 83 71 31 40
CELEBREX 82 37 32 49
DIGOXIN 82 82 32 63
CYMBALTA 76 21 34 28
ESCITALOPRAM OXALATE 74 74 35 58
CITALOPRAM HBR 74 56 35 33
TRICOR 73 36 37 79
CARVEDILOL 71 55 38 21
ATENOLOL 70 39 39 24
SERTRALINE HCL 70 55 39 20
GABAPENTIN 69 31 41 15
BENICAR 69 57 41 72
GLIMEPIRIDE 67 56 43 42
PRADAXA 65 65 44 102
LYRICA 65 24 44 83
GLIPIZIDE ER 63 47 46 104
ABILIFY 62 0 47 106
PIOGLITAZONE HCL 62 51 R 47 106
MICARDIS 62 19 47 106
SINGULAIR 60 42 50 68
COLCRYS 58 56 51 114
GEMFIBROZIL 57 22 52 69
SPIRIVA 56 44 53 46
LANTUS SOLOSTAR 55 17 54 59
HYDROCODONE-ACETAMINOPHEN 52 50 S3 55 7
BUSPIRONE HCL 52 52 55 130
BUMETANIDE 52 52 55 130
TIZANIDINE HCL 50 0 58 140
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 18, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.